1 Goss PE, Baker MA, Carver JP, et al. Inhibitors of carbohydrale processing:a new class of anticancer agenls. Clin Cancer Res,1995,1:935
2 Bowen D, Adir J, White SL, et al. A preliminary pharmacokinelic evalualion of the antimetastatic im-munomodulator swainsonine clinical and toxic implica-tions. Anticancer Res, 1993,13:841
3 Dennis JW, Koch K, Yousefi S, et al. Growth inhibition of human melanoma tumor xenografts in al hy mic nude mice by swainsonine. Cancer Res, 1990, 50:1867
4 Dennis JW. Koch K, Beckner D. Inhibition of hu-man HT29 colon carcinoma growth in Vitro and in vivo by swainsonine and human interferon-α2. J Natl Cancer Inst,1989,81:1028
5 Humphries MH,Matsumoto K, White SL, et al. An assessment of the effects of swainsonine on sur-vival of the mice injected with B16 - F10 melanoma cells. Clin Exp Melastasis, 1990,8:89.
6 Korczak B, Goss P, Fernandez B, et al. Branch-ing N - linked oligosacclarides in breast cancer. Pro-ceedings of the Symposium on Breast Cancer, 5th In-ternational Workshop on Breast Cancer Research and Immunology, San Francisco, 1994
7 Cornil I, Kerbel RS, Dennis JW, et al. Tumor cell surface βl -4 linked galactose binds to lectin(s) on microvascular endothelial cells and contribules to organ colonization. J Cell Biol, 1990,111:773
8 Schaal - Lafon1aine N,Balthazarl C, Hooghe RJ. Modilication of blood - borne arrest properlies of lymphoma cells by inbibitors of proleun glycasylation suggests the existance of endogenous lectins. Carbo-hydr Res,1985,138:315
9 Seftor REB, Seftor EA, Grimes WJ,et al. Hu-man melanona cell imvasion is inhibite in vilro by swainsonine and deoxymannojiri-mycin with a con-comilant decrease in collagenase Ⅳ espression. Melno-ma Res, 1991,1:43
10 Takano R, Nose M, Nishihira I,et al. Increase of β1 -6 - branched oligosaccharides in human esophageal carcnomas invasive againsl surrounding tis-sue in vivo and in vilro. Am J Pathol, 1990,137:1007
11 Korczak B, Dennis JW. Inhibition of N - linked oligosaccharide processing in tumor cells is associaled with enhanced tissue inhibitor of metalloproteinases(TIMP) gene expression. Int J Cancer, 1993,53:63
12 Oldlen K, Breton P, GrzegorzewskiK, et al. The potenlial inporlance ol sw ainsonine in tberpy for can-cers and immunology. Pharmacol Ther, 1991, 50:285
13 Humphries MJ, Matsumoto K, White SL, et al.Allgmentalion of murine natural kill cell activily by swainsonine, a new antimetastalic immunomodulalor. Cancer Res,1988. 48:1410
14 Colombo MP, Modesti A,Parmiani G, et al. Local cylokine availability elcits tumor rejection and systemic immunity through granulocyte-T-lym-phocyle cross-talk. Cancer Res, 1992,52:4853
15 Muchmore A,Decker J, Shaw A, et al. Evi-dence thal high mannose glycopeplides are able 1o functionally interacl with recombinant tumor necrosis faclor and recombinant interleukin Ⅰ. Cancer Res, 1990 50:6285
16 Lucas R, Magez S, De Leys R, et al. Mapping the lectinlike activity of tumor necrosis factor. Sci-ence,1994,263:814
17 White SI, Nagai T, Akiyama SK, el al. Swain-sonine stimulation of the proliferalion and colony forning activily of murine bone marrow Cancer Com-mun,1991,3:83
18 Oredipe OA,White SL, Grzegorzewski K, et al. Proleclive effects of swainsonine on murine survival and bone n1arrow prolifera tion during cyloloxic chenuotherapy. J Natl Cancer Inst, 1991, 83:1149
19 Goss PE, Bapliste J, Fernandes B, e1 al. A study of swainsonine in palients with advanced malignan-cies. Cancer Res,1994, 54:1450 |
